{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:27:22Z","timestamp":1778128042257,"version":"3.51.4"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1454,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:p>The reduced levels of normal immunoglobulin in patients with myeloma may be due to suppression of normal B\u2010cell differentiation. However, reports on the numbers of B cells vary, with some finding decreases consistent with immunoparesis, and others reporting expansions of phenotypically aberrant cells. We have therefore assessed the phenotype and levels of B lymphocytes in patients at presentation (<jats:italic>n<\/jats:italic>\u2003=\u200323), in plateau or complete remission (PB <jats:italic>n<\/jats:italic>\u2003=\u200342, BM <jats:italic>n<\/jats:italic>\u2003=\u200318), and in relapse (PB <jats:italic>n<\/jats:italic>\u2003=\u200317, BM <jats:italic>n<\/jats:italic>\u2003=\u200314), in comparison to normal individuals (<jats:italic>n<\/jats:italic>\u2003=\u200310). Phenotypic analysis was performed using five\u2010parameter flow cytometry, with CD14 used to exclude monocytes where necessary.<\/jats:p><jats:p>We found no evidence of a phenotypically distinctive blood or marrow B\u2010cell population in patients with myeloma, nor of an increase in the levels of any B\u2010cell subset. Numbers of blood CD19<jats:sup>+<\/jats:sup>38<jats:sup>+<\/jats:sup> normal plasma cell precursors were significantly reduced in presentation\/relapse patients, but not in patients in plateau\/remission. Total CD19<jats:sup>+<\/jats:sup> cells were significantly reduced only in patients with circulating myeloma cells, detected by IgH\u2010PCR. In the marrow, CD19<jats:sup>+<\/jats:sup> B cells expressing CD5, CD10, CD34, CD38, CD45<jats:sup>low<\/jats:sup> and Syndecan\u20101 were significantly decreased at presentation\/relapse, but not in patients in plateau\/remission. The majority of these antigens are expressed by normal B\u2010cell progenitors, indicating that myeloma also affects the early stages of B\u2010cell development. The suppression of progenitor cells was not restricted to B\u2010lymphoid differentiation, as total CD34<jats:sup>+<\/jats:sup> cells were also significantly reduced in the marrow of myeloma patients at presentation.<\/jats:p><jats:p>These results indicate that, if neoplastic B cells are present in myeloma, they are low in number and have a phenotype similar to their normal counterparts. Furthermore, there is a reversible suppression of CD19<jats:sup>+<\/jats:sup> B lymphocytes that correlates inversely with disease stage, and specifically affects the early and late stages of normal B\u2010cell differentiation.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.00525.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:57:57Z","timestamp":1047362277000},"page":"176-183","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["B\u2010lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B\u2010cell progenitors and plasma cell precursors"],"prefix":"10.1111","volume":"100","author":[{"given":"Andrew C.","family":"Rawstron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith E.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger G.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"English","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Anthony","family":"Child","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04872.x"},{"issue":"1","key":"e_1_2_6_3_2","first-page":"391","article-title":"CD34+ circulating B cells in multiple myeloma have a rearranged IgH VDJ identical to that of autologous plasma cells as quantitated by in\u2010situ RT\u2010PCR","volume":"88","author":"Belch A.R.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.2.436.436"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.3.1023"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood.V80.7.1818.1818","article-title":"Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients","volume":"80","author":"Billadeau D.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.1.289.289"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V87.5.1972.1972","article-title":"Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells","volume":"87","author":"Chen B.J.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb07646.x"},{"key":"e_1_2_6_10_2","unstructured":"Civin C.I. Trischmann T.M. Fackler M.J. Bernstein I.D. Buhring H. Campos L. Greaves M.F. Kamoun M. Katz D.R. Landsorp P.M. Look A.T. Seed B. Sutherland D.R. Tindle R.W. Uchanska\u2010Ziegler B.(1989) Report on the CD34 cluster workshop. In: Knapp W. D\u00f6rken B. Gilks W.R. Rieber E.P. Schmidt R.E. Stein H. von dem Boine A.E.G.Kr. (eds)Leucocyte Typing IV pp.818825. Oxford University Press."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.3.1091"},{"key":"e_1_2_6_12_2","first-page":"3224","article-title":"No expansion of the pre\u2010B and B\u2010cell compartments in the bone marrow of patients with multiple myeloma","volume":"51","author":"Duperray C.","year":"1991","journal-title":"Cancer Research"},{"key":"e_1_2_6_13_2","first-page":"574","article-title":"Characterization of a new human multiple myeloma cell line, UMJF\u20102, which suppresses antibody production by B\u2010lymphocytes in vitro","volume":"5","author":"Farnen J.P.","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.10.2658.2658"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.300835.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1992.tb03146.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830430108"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood.V78.3.711.711","article-title":"Selective expression of CD45 isoforms defines CALLA+ monoclonal B\u2010lineage cells in peripheral blood from myeloma patients as late stage B cells","volume":"78","author":"Jensen G.S.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830300208"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08210.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.150.4.792"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.49.8.672"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1995.1079"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.72653.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.1.1.27"},{"key":"e_1_2_6_26_2","unstructured":"Sovalat H. Wunder E. Zimmerman R. Serke S.(1994) Multicentric determination of CD34+cells. In: Wunder E. Sovalat H. H\u00e9non P.R. & Serke S. (eds)Hematopoietic Stem Cells: the Mulhouse Manual pp.6778. AlphaMed Press Ohio."},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb06732.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000204253"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1182\/blood.V87.8.3375.bloodjournal8783375","article-title":"Plasma cells induce apoptosis of pre\u2010B cells by interacting with bone marrow stromal cells","volume":"87","author":"Tsujimoto T.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1182\/blood.V81.2.446.bloodjournal812446","article-title":"Expression and function of a receptor for hyaluronan\u2010mediated motility on normal and malignant B lymphocytes","volume":"81","author":"Turley E.A.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_31_2","unstructured":"Zola H.(1995) CD10 workshop panel report. In: Schlossman S.F. Boumsell L. Gilks W. Harlan J.M. Kishimoto T. Morimoto C. Ritz J. Shaw S. Silverstein R. Springer T. Tedder T.F. & Todd R.F. (eds)Leucocyte Typing V Volume 1 pp.505507. Oxford University Press."}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00525.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00525.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2141.1998.00525.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00525.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T06:34:54Z","timestamp":1694414094000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.00525.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1046\/j.1365-2141.1998.00525.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.00525.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}